Open Access
Regen Med Res
Volume 8, 2020
Article Number 3
Number of page(s) 7
Published online 03 December 2020
  1. Bray CC, Walker CM, Spence DD (2017) Orthobiologics in pediatric sports medicine. Orthop Clin North Am 48, 333‒342. [CrossRef] [PubMed] [Google Scholar]
  2. Southworth TM, Naveen NB, Nwachukwu BU, Cole BJ, Frank RM (2019) Orthobiologics for focal articular cartilage defects. Clin Sports Med 38, 109‒122. [CrossRef] [PubMed] [Google Scholar]
  3. Andia I, Maffulli N (2013) Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 9, 721‒730. [CrossRef] [PubMed] [Google Scholar]
  4. Alsousou J, Thompson M, Hulley P, Noble A, Willett K (2009) The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 91, 987‒996. [CrossRef] [PubMed] [Google Scholar]
  5. Campbell KA, Saltzman BM, Mascarenhas R, Khair MM, Verma NN, Bach BR, Cole BJ (2015) Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy 31, 2213‒2221. [CrossRef] [PubMed] [Google Scholar]
  6. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37, 2259‒2272. [CrossRef] [Google Scholar]
  7. Cerza F, Carnì S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, De Biasi G, Ciuffreda M (2012) Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 40, 2822‒2827. [CrossRef] [PubMed] [Google Scholar]
  8. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41, 356‒364. [CrossRef] [PubMed] [Google Scholar]
  9. Simental-Mendía M, Vílchez-Cavazos JF, Peña-Martínez VM, Said-Fernández S, Lara-Arias J, Martínez-Rodríguez HG (2016) Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg 136, 1723‒1732. [CrossRef] [Google Scholar]
  10. Smith PA (2016) Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med 44, 884‒891. [CrossRef] [Google Scholar]
  11. DeLong JM, Russell RP, Mazzocca AD (2012) Platelet-rich plasma: the PAW classification system. Arthroscopy 28, 998‒1009. [CrossRef] [PubMed] [Google Scholar]
  12. Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T (2014) Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J, 4, 3‒9. [CrossRef] [PubMed] [Google Scholar]
  13. Kobayashi Y, Saita Y, Nishio H, Ikeda H, Takazawa Y, Nagao M, Takaku T, Komatsu N, Kaneko K (2016) Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci 21, 683‒689. [CrossRef] [PubMed] [Google Scholar]
  14. Riboh JC, Yanke AB, Cole BJ (2016) Effect of leukocyte concentration on the efficacy of PRP in the treatment of knee OA: response. Am J Sports Med 44, NP66‒NP67. [CrossRef] [Google Scholar]
  15. O'Shaughnessey KM, Panitch A, Woodell-May JE (2011) Blood-derived anti-inflammatory protein solution blocks the effect of IL-1 beta on human macrophages in vitro. Inflamm Res 60, 929‒936. [CrossRef] [Google Scholar]
  16. Pifer MA, Maerz T, Baker KC, Anderson K (2014) Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts. Am J Sports Med 42, 1211‒1218. [CrossRef] [Google Scholar]
  17. Oudelaar BW, Peerbooms JC, Huis In't Veld R, Vochteloo AJH (2019) Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med 47, 479‒487. [CrossRef] [Google Scholar]
  18. Woodell-May J, Matuska A, Oyster M, Welch Z, O'Shaughnessey K, Hoeppner J (2011) Autologous protein solution inhibits MMP-13 production by IL-1 beta and TNF alpha-stimulated human articular chondrocytes. J Orthop Res 29, 1320‒1326. [CrossRef] [PubMed] [Google Scholar]
  19. O'Shaughnessey K, Matuska A, Hoeppner J, Farr J, Klaassen M, Kaeding C, Lattermann C, King W, Woodell-May J (2014) Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors. J Orthop Res 32, 1349‒1355. [CrossRef] [PubMed] [Google Scholar]
  20. Kon E, Engebretsen L, Verdonk P, Nehrer S, Filardo G (2018) Clinical outcomes of knee osteoarthritis treated with an autologous protein solution injection: a 1-year pilot double-blinded randomized controlled trial. Am J Sports Med 46, 171‒180. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.